focus -WSS

focus

author：leisure time 2025-09-06 04:41:44 - browse：1456

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Startup Neumora takes a novel depression drug to Phase 3

WSS

How Medicaid coverage policies for immigrants impact new moms

At Orexo, a ‘turning point’ for everything but digital health

Cosmetics set for new safety regulation. Why the industry is on board

Key House panel plots a new health care package

Sanofi seeks simpler, safer CRISPR sickle cell cure

AI can’t replace a physician’s gut feeling

hotspot

focus

focus

Tori Bowie and the unacceptable rates of Black maternal death

Sanders adds drug shortage policies to pandemic preparedness bill

Medical records are filled with copy

AI can’t replace a physician’s gut feeling

Hollywood unions extend contract negotiations for actors

Group opposing PBM reform sets lobbying record

Psychedelics group wrestles with new pharma identity

Why hospitals are withdrawing from US News rankings

Medicare details structure of new drug price negotiation program

Listen: Wegovy in the brain & pivotal Alzheimer's data

hotspot

FDA approves RSV monoclonal antibody for infants, toddlers

Cosmetics set for new safety regulation. Why the industry is on board

Startup Neumora takes a novel depression drug to Phase 3

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

hotspot

hotspot

knowledge

entertainment